Britannia Life Sciences Inc (TSE:BLAB) has released an update.
Britannia Life Sciences Inc. is set to raise up to CAD$1,000,000 through a non-brokered private placement of debenture units, combining unsecured debentures and common share purchase warrants. The proceeds from the offering, which includes 10% annual interest debentures maturing in 12 months with a possible 12-month extension, will be used for working capital and general corporate purposes. The anticipated closing date of the placement is on or about June 21, 2024, subject to regulatory approvals.
For further insights into TSE:BLAB stock, check out TipRanks’ Stock Analysis page.
